North by Honeywell Pain Stopper Extra Strength tablets recalled for failed stability
Ultra Seal Corporation is recalling North by Honeywell Pain Stopper Extra Strength tablets nationwide because stability testing found out-of-specification results for Salicylic Acid, an aspirin-related compound.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class III, which typically corresponds to a score of 1 or 2. The source text does not report any illnesses, injuries, or deaths. The hazard is a failed stability specification—a quality/manufacturing issue rather than an acute safety threat—making this a moderate precautionary recall.
Plain-English summary
Ultra Seal Corporation is recalling North by Honeywell Pain Stopper Extra Strength tablets (containing Acetaminophen 250 mg, Aspirin 250 mg, and Caffeine 65 mg) distributed nationwide in the United States. The recall was initiated because stability testing identified out-of-specification results for Salicylic Acid, a compound related to aspirin.
The affected product is Lot #AK-9371 with an expiration date of November 21. The product was packaged in cases of 5,000 packets (2 tablets per packet), for a total of 250,000 tablets, and distributed by Honeywell Safety Products USA in Smithfield, Rhode Island.
Consumers who have purchased this product should stop using it and consult their healthcare provider if they have questions or concerns about their health.
The recalled product
- Product
- North by Honeywell PAIN STOPPER EXTRA STRENGTH (Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg) tablets, 2 tablets per packet, Packaged in 5,000 Packets/Case, PO# B121242, Item# 853500-01, Dist. By Honeywell Safety Products USA, Smithfield, RI 02917
- Manufacturer
- Ultra Seal Corporation
- Hazard
- failed-stability-specification
- out-of-specification-salicylic-acid
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AK-9371
- exp. date 21-Nov
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27